CGB 0.00% 2.1¢ cann global limited

Must Say I had feeling a sales drop because of current COVID...

  1. 766 Posts.
    lightbulb Created with Sketch. 167

    Must Say I had feeling a sales drop because of current COVID environment
    Must say its killing us over here business involvement here is dead been dead for last 15 months

    Asia was a ouch

    Domestically is up ( how much in % would be nice to know )

    Discussions with interested distributors, wholesalers and retailers continue in
    Thailand, China and Japan, as well as retailers in the United Kingdom and Europe.

    Well is above true lets hope

    Research
    Prof Michael Barnett is an Australian-based health professional. Michael is trained as a Neurologist (Brain Specialist) and has a practice located in Camperdown.
    Special interests General neurology including central neuro immunology with a focus on Multiple Sclerosis, neuro-op htalmology and neuro physiology.

    Canntab lets all see
    At December 2020 the number of Authorised
    Prescribers was less than 50, at the end of the quarter it was 179. Cann Global is
    well positioned to take advantage of increased patient and prescriber numbers
    with the imminent launch of its Canntab product.

    Willing to say nothing bad give them until 29/10/21 that s 6 months

    zess If Michael Barnett, is willing to help NICM with this project.
    He has read the Technion report based on in vitro and in
    vivo, to assist in the recovery , and to
    stop the progression of, the auto immune
    disease Multiple Sclerosis.

    Who knows we all could be blown away if above stacks up
    Michael Barnett is willing !! he likes the reports



 
watchlist Created with Sketch. Add CGB (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.